Search results
Nurix Therapeutics (NASDAQ:NRIX) Trading Up 4.4% on Analyst Upgrade
ETF DAILY NEWS· 7 days agoNurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) shares were up 4.4% on Tuesday after HC Wainwright raised their price target on the stock from $19.00 to $26.00. HC Wainwright currently ...
Who should I vote for? The main parties’ policies at a glance
The Telegraph via Yahoo News· 1 day agoThe party also plan to “double nature” by 2050, pass a clean air act and cut green house gases to...
Pinetree Capital (TSE:PNP) Trading 6% Higher
ETF DAILY NEWS· 5 days agoShares of Pinetree Capital Ltd. (TSE:PNP – Get Free Report) shot up 6% on Tuesday . The company traded as high as C$6.20 and last traded at C$6.20. 3,851 shares changed hands during trading, ...
Scarborough Advisors LLC Invests $32,000 in Blackstone Inc. (NYSE:BX)
ETF DAILY NEWS· 7 days agoScarborough Advisors LLC purchased a new position in shares of Blackstone Inc. (NYSE:BX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with ...
Biomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Update
ETF DAILY NEWS· 7 days agoBiomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) saw a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 11,930,000 shares, a drop of 9.2% ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target Cut to $10.00 by Analysts at Stifel Nicolaus
ETF DAILY NEWS· 7 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective reduced by Stifel Nicolaus from $32.00 to $10.00 in a research report report published on Tuesday morning, Benzinga ...
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Purchased by Nomura Holdings Inc.
ETF DAILY NEWS· 7 days agoNomura Holdings Inc. grew its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.8% during the fourth quarter, according to its most recent Form 13F filing with the ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by Wedbush
ETF DAILY NEWS· 7 days agoWedbush downgraded shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday morning, MarketBeat ...
Nurix Therapeutics (NASDAQ:NRIX) Price Target Increased to $26.00 by Analysts at HC Wainwright
ETF DAILY NEWS· 7 days agoNurix Therapeutics (NASDAQ:NRIX – Free Report) had its price objective increased by HC Wainwright from $19.00 to $26.00 in a research report released on Tuesday, Benzinga reports. Stephens initiated ...